Indonesia
· Delayed Price · Currency is IDR PT Kalbe Farma Tbk. Statistics
Total Valuation
PT Kalbe Farma Tbk. has a market cap or net worth of IDR 79.54 trillion. The enterprise value is 78.44 trillion.
| Market Cap | 79.54T |
| Enterprise Value | 78.44T |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | May 29, 2024 |
Share Statistics
PT Kalbe Farma Tbk. has 46.24 billion shares outstanding. The number of shares has decreased by -0.60% in one year.
| Shares Outstanding | 46.24B |
| Shares Change (YoY) | -0.60% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 0.25% |
| Owned by Institutions (%) | 14.26% |
| Float | 18.94B |
Valuation Ratios
The trailing PE ratio is 26.10 and the forward PE ratio is 25.31. PT Kalbe Farma Tbk.'s PEG ratio is 1.86.
| PE Ratio | 26.10 |
| Forward PE | 25.31 |
| PS Ratio | 2.51 |
| PB Ratio | 3.65 |
| P/FCF Ratio | 20.99 |
| PEG Ratio | 1.86 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.59, with an EV/FCF ratio of 20.70.
| EV / Earnings | 25.78 |
| EV / Sales | 2.48 |
| EV / EBITDA | 16.59 |
| EV / EBIT | 19.62 |
| EV / FCF | 20.70 |
Financial Position
The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.96 |
| Quick Ratio | 2.24 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 0.27 |
| Interest Coverage | 56.13 |
Financial Efficiency
Return on equity (ROE) is 13.65% and return on invested capital (ROIC) is 10.32%.
| Return on Equity (ROE) | 13.65% |
| Return on Assets (ROA) | 8.88% |
| Return on Capital (ROIC) | 10.32% |
| Revenue Per Employee | 2.43B |
| Profits Per Employee | 234.21M |
| Employee Count | 13,108 |
| Asset Turnover | 1.13 |
| Inventory Turnover | 2.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.99% in the last 52 weeks. The beta is 0.21, so PT Kalbe Farma Tbk.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -1.99% |
| 50-Day Moving Average | 1,702.50 |
| 200-Day Moving Average | 1,569.85 |
| Relative Strength Index (RSI) | 51.70 |
| Average Volume (20 Days) | 29,077,820 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Kalbe Farma Tbk. had revenue of IDR 31.60 trillion and earned 3.04 trillion in profits. Earnings per share was 65.89.
| Revenue | 31.60T |
| Gross Profit | 11.89T |
| Operating Income | 3.98T |
| Pretax Income | 4.07T |
| Net Income | 3.04T |
| EBITDA | 4.66T |
| EBIT | 3.98T |
| Earnings Per Share (EPS) | 65.89 |
Balance Sheet
The company has 3.85 trillion in cash and 1.02 trillion in debt, giving a net cash position of 2.83 trillion or 61.25 per share.
| Cash & Cash Equivalents | 3.85T |
| Total Debt | 1.02T |
| Net Cash | 2.83T |
| Net Cash Per Share | 61.25 |
| Equity (Book Value) | 23.54T |
| Book Value Per Share | 471.50 |
| Working Capital | 12.62T |
Cash Flow
In the last 12 months, operating cash flow was 4.74 trillion and capital expenditures -954.30 billion, giving a free cash flow of 3.79 trillion.
| Operating Cash Flow | 4.74T |
| Capital Expenditures | -954.30B |
| Free Cash Flow | 3.79T |
| FCF Per Share | 81.94 |
Margins
Gross margin is 37.64%, with operating and profit margins of 12.59% and 9.63%.
| Gross Margin | 37.64% |
| Operating Margin | 12.59% |
| Pretax Margin | 12.87% |
| Profit Margin | 9.63% |
| EBITDA Margin | 14.76% |
| EBIT Margin | 12.59% |
| FCF Margin | 11.99% |
Dividends & Yields
This stock pays an annual dividend of 31.00, which amounts to a dividend yield of 1.80%.
| Dividend Per Share | 31.00 |
| Dividend Yield | 1.80% |
| Dividend Growth (YoY) | -18.42% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 47.23% |
| Buyback Yield | 0.60% |
| Shareholder Yield | 2.41% |
| Earnings Yield | 3.83% |
| FCF Yield | 4.76% |
Stock Splits
The last stock split was on October 8, 2012. It was a forward split with a ratio of 5.
| Last Split Date | Oct 8, 2012 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
PT Kalbe Farma Tbk. has an Altman Z-Score of 12.26.
| Altman Z-Score | 12.26 |
| Piotroski F-Score | n/a |